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laboratories have further suggested that 
troglitazone and ciglitazone mediate 
antiproliferative effects through a com-
plex of PPARγ-independent mechanisms 
(Chou et al., 2007). Evidence indicates 
that troglitazone and ciglitazone block 
BH3 domain–mediated interactions 
between the antiapoptotic Bcl-2 (B-cell 
leukemia/lymphoma 2) members Bcl-2/
Bcl-xL and proapoptotic Bcl-2 members. 
Moreover, these TZDs facilitate the 
degradation of cyclin D1 and caspase-
8-related, Fas-associated, death domain 
protein–like, IL-l-converting enzyme–
inhibitory protein through proteasome-
mediated proteolysis, and downregulate 
the gene expression of prostate-specific 
antigen by inhibiting activation of the 
androgen response elements in the pro-
moter region (Chou et al., 2007).
Further work has indicated that in 
mouse melanoma S91 cells, activation 
of PPARγ induces events resembling dif-
ferentiation, such as growth arrest accom-
panied by apoptosis, spindle morphol-
ogy, and enhanced tyrosinase expression. 
These events were preceded by an initial 
transient increase in expression of the 
microphthalmia-associated transcription 
factor (MITF) gene promoter. Exposure 
to a PPARγ ligand, ciglitazone, caused a 
gradual decrease in MITF. β-Catenin, an 
MITF transcriptional activator, showed a 
similar pattern of decline during ciglita-
zone treatment, indicating that activated 
PPARγ inhibits the Wnt/β-catenin pathway 
through the induction of β-catenin protea-
somal degradation (Grabacka et al., 2008).
Hoeck and co-workers hypothesized 
that the metastatic potential of melano-
ma cells is dependent on the activation 
of the MITF and Wnt/β-catenin pathways; 
recently, they demonstrated that these 
pathways are of critical importance in 
melanoma biology based on their analy-
sis of gene profiles of large sets of human 
melanoma cell lines(Hoeck et al., 2006). 
Subsequent work on human melanoma 
tissues demonstrated that MITF gene 
amplification in melanoma metastases 
was a prognostic marker for patient sur-
vival (Ugurel et al., 2007).
The work reported by Botton et al. 
(2009) focuses on ciglitazone-induced 
effects on normal melanocytes and 
melanoma cells. Biological effects, 
such as apoptosis and cell cycle arrest, 
which were reported to be ciglitazone 
concentration–dependent and occurred 
only in low concentrations, depended on 
the PPARγ pathway. These in vitro obser-
vations were accompanied by substantial 
tumor growth inhibition in nude mice.
These data and an accumulating lit-
erature point to TZDs as potential can-
didates for melanoma treatment. More 
important, dissociation of the effects of 
TZDs on apoptosis from their original 
pharmacological activity (i.e., PPARγ 
activation) provides a molecular basis 
for using these compounds to develop 
molecularly targeted anticancer agents.
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How the Skin Can Tell Time
Mikhail Geyfman1 and Bogi Andersen1
The mammalian central circadian pacemaker, which is located in the suprachi-
asmatic nucleus (SCN) of the hypothalamus, synchronizes and entrains clocks 
found in peripheral tissues. Skin harbors an active circadian clock that is under 
the influence of the central clock. This clock, which probably operates in most—
perhaps all—types of skin cells, may influence the regulation of several circadian 
physiological phenomena, including cell proliferation.
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circadian clock mechanisms
Rotation of the Earth leads to light–dark 
cycles and changes in environmental 
temperature over the course of 24 hours. 
In organisms as diverse as cyanobac-
teria, flies, and humans, evolution has 
favored mechanisms whereby activity 
and multiple physiological processes are 
coordinated with periodic light–dark 
cycles (Bell-Pedersen et al., 2005). In 
mammals, such circadian (from the Latin 
circa, “about,” and dies, “day”) regulation 
is the defining feature of the core master 
oscillator located in the suprachiasmatic 
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nucleus (SCN) of the anterior hypothala-
mus (Figure 1). The SCN receives light 
signals transmitted from the retina via the 
retinohypothalamic tract; these signals 
entrain the SCN clock to the light–dark 
cycle. In addition to the central clock, 
peripheral clocks are present in most, if 
not all, cells of the body. These periph-
eral clocks are thought to be indepen-
dent and self-sustaining, as demonstrat-
ed in explants, cell cultures, and single 
cells, but they depend on synchronizing 
signals from the SCN for coordinated 
oscillation (Lui et al., 2007; Welsh et 
al., 2004). The SCN is thought to act on 
the subsidiary peripheral clocks through 
neural and humoral signals (Lowrey and 
Takahashi, 2004).
To achieve circadian regulation, an 
intricate clock mechanism has evolved. 
At a molecular level, the mammalian 
circadian clock consists of positive and 
negative regulatory loops (Figure 2). The 
positive components of the circadian 
clock consist of CLOCK and BMAL1, 
bHLH (basic helix–loop–helix), and PAS 
(PER-ARNT-SIM) domain transcription 
factors that form a heterodimer and bind 
to E-boxes within promoters of their 
target genes. Among genes activated 
by CLOCK/BMAL1 are negative com-
ponents of the circadian clock, Per1-3 
and Cry1-2, as well as other E-box-
containing genes referred to as CLOCK-
controlled genes (CCGs). As protein 
products of Pers and Crys accumulate in 
the nucleus, they inhibit the activity of 
CLOCK/BMAL1, inactivating their own 
expression. This process leads to circa-
dian changes in the RNA and protein 
levels of PERs, CRYs, and other targets 
activated by CLOCK/BMAL1 in the SCN 
and peripheral tissues. An additional 
regulatory loop consisting of REV-ERBα 
and RORα, which serve as transcrip-
tional inhibitors and activators of Bma1l, 
respectively, is responsible for the daily 
oscillation of Bmal1 mRNA levels. A key 
feature of circadian clocks, required to 
generate oscillation, is a lag between 
the transcriptional activation of Pers and 
Crys and the nuclear translocation of the 
repressor proteins they encode. Also of 
importance are the short half-lives of Per 
and Cry mRNAs and proteins, mediated 
in part by casein kinase–mediated 
phosphorylation and proteosomal deg-
radation (Lowrey and Takahashi, 2004).
Figure 2. the mammalian circadian clock. CLOCK and BMAL1 form a heterodimer that binds 
to E-boxes in regulatory regions to activate transcription of target genes. Pers (periods) and Crys 
(cryptochromes) are among the genes activated by CLOCK/BMAL1. PERs and CRYs form heterodimers 
that translocate into the nucleus and bind to the CLOCK/BMAL1 heterodimer, thus inhibiting its ability 
to activate transcription. Consequently, PERs and CRYs inhibit their own transcription via a negative 
feedback loop, thereby generating periodic expression over 24 hours. Other genes activated by CLOCK/
BMAL1 are referred to as CLOCK-controlled genes (CCGs). These include the D-box binding protein 
(DBP). REV-ERBα and RORα are responsible for the oscillation of Bmal1 mRNA by repressing and 
activating Bmal1 transcription, respectively, by binding to ROR response elements (RRE). The time lapse 
between transcription of Pers and Crys and nuclear entry of their gene products, as well as regulated 
degradation of clock components, is responsible for the oscillation of circadian clocks. Casein kinase 
(CK) phosphorylates PERs, thus regulating both nuclear import and degradation.
Figure 1. Hierarchical organization of the mammalian circadian clock. The suprachiasmatic 
nucleus (SCN), located in the anterior hypothalamus, receives light stimuli from the retina via the 
retinohypothalamic tract. The oscillation in SCN neurons is entrained by light stimulus and results in 
a humoral or neural output that is received and interpreted by numerous peripheral clocks. Peripheral 
clocks produce periodic transcriptional and posttranslational responses that ultimately produce 
behavioral, metabolic, and physiological output. The skin is characterized by the presence of rapidly 
dividing cell populations in the epidermis and hair follicles, as well as periodic fluctuations in several 
biophysical parameters that could be directly or indirectly regulated by the circadian clock. 
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the skin has a clock
Previous studies demonstrated expres-
sion of clock proteins in keratinocytes, 
dermal fibroblasts, and melanoma 
cells (Zanello et al., 2000), as well 
as circadian oscillation of clock gene 
expression in skin and oral mucosa 
(Bjarnason et al., 2001). In oral muco-
sa, the expression of clock genes cor-
related with the circadian variation 
in S phase activity (Bjarnason et al., 
2001). Within skin, the circadian clock 
is active within both dermal fibroblasts 
and keratinocytes (Brown et al., 2005), 
and most likely within other cell types 
as well. Tanioka and co-workers (2009, 
this issue) demonstrate the presence 
of circadian oscillation in mouse skin 
under conditions of constant darkness 
(Figure 3a), indicating, as expected, 
that light does not act directly on the 
skin clock. On the other hand, the 
authors show that ablation of the SCN 
leads to arrhythmic clock gene expres-
sion in the skin; the CLOCK-controlled 
gene Dbp shows low constant expres-
sion (Figure 3b). These findings, which 
are similar to previous results in the 
liver and kidney (Guo et al., 2005), 
indicate that the skin clock is under 
the influence of the SCN. This does not 
necessarily mean that the SCN drives 
the peripheral clocks in individual cells 
of the skin. More likely, the removal of 
the SCN leads to asynchronous clock 
activity among different skin cells. If 
SCN ablation leads to drifting out of 
phase among individual skin cells, 
this will appear as arrhythmicity when 
measured in the total cell population 
of whole skin (Welsh et al., 2004). 
Furthermore, the authors demon-
strate the loss of circadian clock gene 
oscillation in the skin of Cry1–/–/
Cry2–/– mice (Figure 3C). In contrast 
to the SCN ablation experiments, Dbp 
and Per2 expression in skin is constitu-
tively high in the Cry1–/–/Cry2–/– mice, 
consistent with the role of CRYs in the 
negative feedback loop. These findings 
support the notion of an active, clas-
sic clock mechanism within the skin. 
Future studies taking advantage of tis-
sue-specific deletions of clock genes 
will elucidate the relationship between 
the central clock and circadian regula-
tion within the skin.
Mouse skin is a complex organ 
populated by many cell types, includ-
ing epidermal keratinocytes, melano-
cytes, dermal fibroblasts, adipocytes, 
neurons, immune cells, and vascular 
cells, as well as many appendage-spe-
cific cell types, including hair follicle 
keratinocytes, sebocytes, and eccrine 
gland cells. Although the authors report 
the expression of mPER2 protein in 
keratinocytes and dermal fibroblasts, it 
remains to be determined whether dif-
ferences exist in expression levels for 
clock genes among the different cell 
types within the skin. Although Tanioka 
et al. (2009) provide strong support 
for the existence of a peripheral circa-
dian clock in mouse skin as well as its 
dependence on synchronizing signaling 
originating from the SCN, the functions 
of clock genes within the skin remain 
to be elucidated.
Potential roles for the skin clock
Circadian mechanisms within the brain 
and liver regulate wake–sleep behavior 
and metabolism, respectively. The role 
of the circadian clock within the skin 
is currently unknown. However, given 
the direct environmental exposure of 
the skin, as well as its cellular complex-
ity, it is likely that circadian clocks may 
regulate a variety of distinct physiologi-
cal responses depending on cell types. 
Therefore, it is probably simplistic to 
talk about a singular “skin clock.”
Insights gained from recent func-
tional studies in other peripheral clocks, 
as well as information about circadian 
physiological phenomena in the skin, 
allow speculation about the poten-
tial role of circadian clocks within the 
skin. As early as 1948, Bullough noted 
that mitotic activity of mouse epidermal 
keratinocytes varied in a coordinated 
and periodic fashion over the course of 
24 hours (Bullough, 1948). Nearly five 
decades later, a direct link between cell 
cycle regulation and the circadian clock 
in actively dividing tissue was made in a 
study using mouse liver regeneration as 
a model. Matsuo et al. discovered that 
after hepatectomy the circadian clock 
may have a role in affecting cell divi-
sion by regulating the expression of the 
E-box–containing gene Wee1, which 
encodes a kinase involved in G2/M tran-
sition (Matsuo et al., 2003). Although 
a correlation between circadian gene 
expression and cell proliferation in oral 
mucosa has been noted (Bjarnason et 
al., 2001), there are no functional data 
demonstrating a role for clock genes 
in cell division within the skin or other 
stratified epithelia. Nevertheless, skin is 
a likely candidate for the existence of 
such regulation because of the presence 
of continuously dividing cells, much as 
in the regenerating liver.
Figure 3. Features of the “skin clock.” Tanioka et al. (2009) demonstrated the circadian oscillation 
of clock genes and CLOCK-controlled gene Dbp in 24-hour constant darkness (a). When the SCN 
is physically ablated, CLOCK-controlled genes are expressed at a low level without oscillation. This 
observation demonstrates the influence of the central SCN on the skin peripheral clock (b). When the 
clock is genetically ablated in the Cry1–/–/Cry2–/– mouse model, clock genes do not oscillate and are 
expressed at a constitutively high level. This is consistent with the negative feedback role of CRYs (c).  
The black bar at the bottom indicates total darkness. ZT, Zeitgeber time.
|The circadian clock is active in fibroblasts and keratinocytes.
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Skin performs a variety of functions, 
including barrier formation and thermal 
regulation. The environmental exposure 
of skin to UV radiation and temperature 
varies dramatically between day and 
night. It is therefore not surprising that 
several biophysical and physiological 
parameters of human skin were found 
to have periodic daily fluctuations. A 
controlled study using healthy women 
reported that skin temperature, sebum 
production, pH, capacitance (measure 
of skin hydration), and transepidermal 
water loss (measure of barrier function) 
varied in a circadian manner (Le Fur 
et al., 2001). Circadian clock mecha-
nisms are possible modulators of these 
circadian phenomena, which are most 
likely mediated by a variety of cell types 
within the skin. Circadian timing mecha-
nisms are also sensitive to day length 
and temperature, and therefore circa-
dian clock mechanisms are candidates 
for the regulation of seasonal phenom-
ena within the skin. Interestingly, several 
skin diseases do exhibit seasonal change 
in severity (Weiss et al., 2008). In the 
future, the availability of mouse models 
with mutations in genes encoding sev-
eral clock components may allow the 
role of the circadian clock in skin biol-
ogy to be tested. The study of Tanioka et 
al. (2009) should stimulate research into 
connections among the circadian clock 
and physiological responses and diseas-
es of the skin.
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Scarring Alopecia and the  
PPAR-γ Connection
Matthew J. Harries1 and Ralf Paus1,2
The pathobiology of primary cicatricial (“scarring”) alopecia (PCA) remains 
poorly understood and underinvestigated. In this issue, Karnik et al. identify a 
previously unsuspected player, peroxisome proliferator-activated receptor-γ 
(PPARγ), in the pathogenesis of the most frequent form of PCA, lichen plano-
pilaris (LPP). The authors show that PPARγ is required for maintenance of a func-
tional epithelial stem cell compartment in murine hair follicles, that the target-
ed deletion of PPARγ in the bulge/isthmus area of the hair follicle epithelium 
generates a skin pathology that resembles LPP, and that LPP patients show gene 
expression changes that indicate a defect in lipid metabolism and peroxisome 
biogenesis. This study invites the revisitation of many open questions in PCA 
pathobiology and the exploration of new avenues for future PCA management.
Journal of Investigative Dermatology (2009), 129, 1066–1070. doi:10.1038/jid.2008.425
Cicatricial (“scarring”) alopecias may be primary, with the hair follicle being the 
main target of a detrimental inflammatory process, or secondary, with follicle dam-
age occurring coincidentally during a more generalized destructive event within the 
skin (e.g., thermal burn, trauma, infec-
tion, ionizing irradiation). Primary cica-
tricial alopecia (PCA) is a diverse group 
of inflammatory scalp disorders that tar-
get and destroy hair follicles, eventually 
resulting in permanent alopecia. The 
reliable diagnosis and effective manage-
ment of these infrequent but often psy-
chologically devastating forms of irre-
versible hair loss have long constituted 
a major unmet clinical need (Harries et 
al., 2008b; Olsen et al., 2003).The main 
diagnostic hallmarks of PCA are the 
loss of visible follicular ostia on clinical 
inspection and the destruction of fol-
licles, with subsequent replacement by 
scar-like fibrous tissue on histopatholog-
ical examination (Harries et al., 2009).
Unfortunately, the etiology and 
pathogenesis of PCA are still largely 
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